Time to stop managing failure and start preventing it.
STROKE is one of the most predictable catastrophes in Scottish medicine. We know who is at risk, we know why strokes happen, and we know how to prevent a large proportion of them. Yet since the establishment of the Scottish Parliament, Scotland has never made upstream stroke prevention the organising principle of its national stroke strategy. Not once. Not despite decades of data, widening health inequalities, and repeated political commitments to prevention.
Instead, we have built a system that excels at response and hesitates at anticipation. We intervene late, expensively, and heroically, while tolerating the quiet accumulation of risk that makes those interventions necessary in the first place.
This is not a failure of knowledge. It is a failure of choice.
The preventable burden we continue to accept
Most strokes in Scotland are not sudden, unforeseeable events. They are the end result of years of poorly controlled hypertension, undiagnosed or untreated atrial fibrillation, hyperlipidaemia, diabetes, smoking, and deprivation. These are not controversial drivers of disease. They are well described, routinely measured, and eminently modifiable.
Blood pressure control alone reduces stroke risk dramatically. Anticoagulation in atrial fibrillation remains one of the most effective interventions in modern medicine. Statins, smoking cessation, and structured diabetes management are cheap, safe, and scalable. Their benefits accrue across the population, not just to those who reach hospital in time.
And yet, despite this clarity, Scotland continues to invest disproportionately in late-stage rescue while leaving prevention fragmented, underpowered, and poorly owned.
The diminishing returns of rescue medicine
Hyperacute stroke services matter. Thrombolysis and thrombectomy save lives and reduce disability. No serious reform agenda would argue otherwise. But these interventions apply to a minority of patients, within narrow time windows, after irreversible brain injury has already begun.
As systems mature, the marginal gains from expanding acute capacity fall. Each additional investment delivers less population benefit than the last. Stroke incidence remains unchanged. Inequalities persist. The same communities continue to experience higher risk and worse outcomes.
Scotland has become increasingly adept at managing the consequences of stroke while remaining strangely reluctant to confront its causes.
Nowhere is this imbalance clearer than in how stroke services are accessed.
For decades, the NHS has relied on nurse-based gatekeeping in stroke care to compensate for gaps in immediate specialist availability. This model emerged out of necessity, not design, and it has persisted long after its limitations became obvious. In no other critical illness do we routinely accept delayed access to senior clinical decision-making as an acceptable norm.
The NHS must move on from this approach.
Critical illnesses demand immediate specialist input, not layered escalation through workarounds created by workforce shortages. In stroke care, nurse-led triage has too often become a substitute for real-time medical expertise. The consequences are predictable: missed opportunities for time-sensitive treatment, defensive admissions, and unnecessary burden placed on local medical teams assessing patients after therapeutic windows have already closed.
This is not a criticism of nurses. It is an indictment of a system that has normalised improvisation where design should exist.
Scotland already has the ingredients to do better. GP records allow precise identification of individuals at highest stroke risk: those with uncontrolled hypertension, untreated atrial fibrillation, high CHA₂DS₂-VASc or QRISK scores, and multiple modifiable risk factors. These patients are known to the system long before they present to hospital.
What has been missing is a delivery model.
A national programme of risk-targeted, community-based stroke prevention clinics could be established rapidly using existing data and protocolised care. High-risk individuals would be actively invited, not passively discovered. Interventions would be standardised, supervised, and focused on outcomes that matter: blood pressure control, anticoagulation uptake, statin use, and smoking cessation.
This is not mass screening. It is precision prevention — targeted where the return is greatest and the harms minimal.
STROKEBASE: modernising stroke decision-making
Prevention alone, however, is not enough. Scotland also needs to modernise how stroke decisions are made in real time.
The solution is neither radical nor untested. It already exists elsewhere in the NHS.
Just as TOXBASE provides immediate specialist toxicology advice to clinicians across the UK, Scotland should establish a national Scottish Stroke Service — STROKEBASE — a 24/7 clinician-to-clinician advisory service accessible to every GP practice and every emergency department.
STROKEBASE would be staffed by stroke physicians and experienced stroke clinicians, providing immediate medical advice at the point of uncertainty: suspected stroke, post-window presentations, borderline eligibility decisions, and complex risk–benefit assessments. It would replace fragmented escalation pathways with a single, authoritative source of expertise.
To ensure round-the-clock coverage while Scotland trains and expands its stroke workforce, we could use some clinicians currently based overseas, under the caveat they are working within NHS governance, data protection, and clinical accountability frameworks. This would not replace local services. It would support them — immediately, consistently, and safely.
The result would be fewer missed treatments, fewer unnecessary admissions, and faster, more confident decision-making across the system.
This is not an argument against stroke units or specialist centres. They remain essential. But beyond a certain point, expanding rescue medicine yields diminishing returns, while prevention and system redesign deliver compounding benefits.
The question facing Scotland is not whether it can afford to invest in upstream prevention and modern decision support. It is whether it can afford not to.
For over twenty years, the Scottish Parliament has deferred this choice. Responsibility has been diffused, incentives misaligned, and prevention treated as aspiration rather than infrastructure. The result is a system that manages failure well while quietly accepting preventable harm.
Stroke exposes that contradiction more clearly than almost any other condition.
Scotland does not lack evidence, expertise, or data. What it lacks is the will to reorient its stroke strategy toward preventing disease and delivering specialist expertise when it matters most.
A national commitment to risk-targeted prevention, combined with a modernised, specialist-led decision support system like STROKEBASE, would save lives, reduce inequality, and deliver better value than any further marginal expansion of late-stage intervention alone.
The tools are already in our hands. The delay is no longer defensible.
Established in 2006, ThinkScotland is not for profit (it makes a loss) and relies on donations to continue publishing our wide range of opinions – you can follow us on X here – like and comment on facebook here and support ThinkScotland by making a donation here.
Photo by pixs4u via Adobe Stock
